Kevin P O'Rourke Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

12/2015

Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin P O'Rourke Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 06/2015
4	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 01/2017
3	Neoplasm Metastasis (Metastasis) 11/2020 - 01/2017
1	Colitis 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Adenoma (Adenomas) 01/2020
1	Rectal Neoplasms (Rectal Cancer) 10/2019
1	Tetraploidy 01/2018
1	Adenocarcinoma 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2015

Drug/Important Bio-Agent (IBA)

2	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2015
2	Doxycycline (Periostat)FDA LinkGeneric 01/2022 - 06/2015
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 11/2020 - 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	Interleukin-22 (IL-22)IBA 12/2015

Therapy/Procedure

1	Therapeutics 01/2022
1	Radiotherapy 10/2019
1	Drug Therapy (Chemotherapy) 10/2019
1	Transplantation 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2015